The Brazilian Cough Syrup That Flew Under the Radar
Helix was introduced around 2019 by a small manufacturer called Farmacêutica Pseihederase as an over-the-counter expectorant. It gained its unusual profile not from the product itself but from the way it was marketed on social media platforms, particularly TikTok and Instagram, where users began sharing unverified claims about its effectiveness and safety. The term "Xarope Helix" (helix syrup) became a search trend in early 2024 after several viral posts compared it to prescription-strength medications without any supporting clinical data. The controversy centers on three main points. First, the ingredient list on the packaging differs from what is disclosed on the manufacturer's website. The box lists guaifenesin and menthol as active ingredients. The online product page adds "proprietary herbal extract blend" without specifying which herbs or at what concentration. This discrepancy drew attention from Brazilian health watchdog ANVISA, which issued a formal inquiry to the company in late 2023. Second, the viral videos claimed the syrup could treat chronic bronchitis and even ease asthma symptoms. These are off-label uses that carry real risk, especially for people who self-medicate instead of consulting a doctor. I spoke with a pulmonologist in São Paulo who confirmed seeing several patients who delayed proper treatment after trying the syrup for persistent coughs. None of them had serious outcomes, but the delay was unnecessary.
Third, pricing became an issue. The syrup retails for approximately R$28 per 120ml bottle, which is higher than comparable OTC options like carbocisteine-based syrups that cost around R$15 at the same volume. Users on forums argued the premium price was unjustified given the lack of published clinical trials for the product.
How the Product Actually Works
Guaifenesin is a well-established expectorant. It works by increasing the volume and reducing the viscosity of secretions in the trachea and bronchi, making it easier to clear mucus through coughing. The typical adult dose is 200-400mg every four hours, not to exceed 2400mg daily. Menthol provides a mild topical analgesic effect on the throat, which is why many people perceive it as "soothing" even though it doesn't treat the underlying cause of the cough. The undisclosed herbal blend is the unknown variable. Without knowing the composition, it is impossible to assess potential interactions with other medications. This is where I ran into a practical problem last year. A colleague asked me to review a case where a patient on warfarin also took the syrup and started experiencing elevated INR levels. We couldn't confirm the exact interaction because the label didn't disclose the full ingredient list. The workaround was straightforward: we advised stopping the syrup immediately and switching to a guaifenesin-only product with a fully transparent label. The INR stabilized within a week. This is not an edge case. Any supplement or herbal compound in an OTC product has the potential to interact with anticoagulants, SSRIs, or blood pressure medications. The lack of disclosure makes that risk harder to manage.
Get the Full Details
What ANVISA Has Said So Far
As of mid-2024, ANVISA has not banned the product. The inquiry is still open. The agency has requested that Pseihederase submit full clinical documentation and reconcile the packaging with the website listing. The company has complied partially, releasing a revised label that now includes a disclaimer stating the product is "not intended to diagnose, treat, cure, or prevent any disease." This is standard language but does not address the original concerns about the undisclosed ingredients. ANVISA has also issued a public advisory warning consumers to report any adverse reactions. They have not recommended stopping use outright, which frustrates some physicians who feel a stronger stance is warranted given the information gap.
Practical Advice If You Are Considering Using It
The most straightforward approach is to look for alternatives with complete ingredient transparency. Guaifenesin alone is available from multiple manufacturers at lower price points. Products like Mucinex or generic guaifenesin tablets provide the same active mechanism without the marketing premium or the unknown herbal variables. If you are already using Helix syrup, check your medication list for potential interactions, particularly if you take blood thinners, antidepressants, or antihypertensives. The risk is low but real, and the incomplete label makes informed decision-making difficult. There is no way to know what you are swallowing beyond what the bottle claims, and that uncertainty is itself the problem. The viral controversy around this product will likely fade as new trends emerge. But the underlying issue — a product with partial disclosure operating in a regulatory gray area — remains relevant for any consumer-grade supplement or medication sold without full transparency. That pattern is not unique to Helix. It appears frequently in the OTC space, and it is worth treating with the same caution you would apply to any medication whose complete composition you cannot verify.
